Open original FDA record ↗Recall record
- FDA identifier
- Z-2388-2010
- Company in FDA record
- Beckman Coulter Inc.
- FDA classification date
- Sep 9, 2010
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 20, 2026
- Recall classification
- Unknown — no matched enforcement classification
Reason stated in the source
UniCel DxC and Synchron LX instruments produced inaccurate (low) GLUCm results. False low results could affect or delay diagnosis or treatment.
Source facts
- Action
- Beckman Coulter issued an "Urgent: Product Corrective Action" (PCA) letter dated April 2010 to all consignees, identifying the reason for the recall, the affected lots, and the potential for inaccurate GLUCm results due to bubble retention and short samples. Customers were instructed to: 1) establish specific protocols for samples from defined patient populations or sample types, which could include running specimens using GLUCm in duplicate or using cartridge glucose. 2) To reduce the possibility of inaccurate results, ensure that all elements are properly installed and secured, the sample probe is adequately tightened, and proper sample volume and integrity are maintained. A copy of the PCA letter will also be included in all new instrument ship kits. Consignees were instructed to complete and return an enclosed response form. Consignees can contact Beckman Coulter at 1-973-956-5300 .
- Initiated
- 2010-04-15
- Root cause
- Other
- Terminated
- 2013-12-31
- Distribution
- Worldwide Distribution: USA and Canada
- Recall number
- Z-2388-2010
- Recall status
- Terminated
- CDRH record ID
- 90668
- FDA classified
- 2010-09-09
- Recall event number
- 55359